These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27401736)

  • 21. Elevated serum level of IL-4 in neuromyelitis optica and multiple sclerosis patients.
    Tahani S; Dehghani L; Jahanbani-Ardakani H; Shaygannejad V; Fazli A; Hamidavi A; Eskandari N
    J Immunoassay Immunochem; 2019; 40(5):555-563. PubMed ID: 31422745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response effect of interleukin (IL)-1β, tumour necrosis factor (TNF)-α, and interferon-γ on the in vitro production of epithelial neutrophil activating peptide-78 (ENA-78), IL-8, and IL-6 by human endometrial stromal cells.
    Bersinger NA; Günthert AR; McKinnon B; Johann S; Mueller MD
    Arch Gynecol Obstet; 2011 Jun; 283(6):1291-6. PubMed ID: 20505949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
    Yamasaki R; Matsushita T; Fukazawa T; Yokoyama K; Fujihara K; Ogino M; Yokota T; Miyamoto K; Niino M; Nomura K; Tomioka R; Tanaka M; Kawachi I; Ohashi T; Kaida K; Matsui M; Nakatsuji Y; Ochi H; Fukaura H; Kanda T; Nagaishi A; Togo K; Mizusawa H; Murai H; Kira J
    Mult Scler; 2016 Sep; 22(10):1337-48. PubMed ID: 26564994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
    Hertwig L; Pache F; Romero-Suarez S; Stürner KH; Borisow N; Behrens J; Bellmann-Strobl J; Seeger B; Asselborn N; Ruprecht K; Millward JM; Infante-Duarte C; Paul F
    Mult Scler; 2016 Feb; 22(2):160-73. PubMed ID: 26540731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability.
    Tomizawa Y; Yokoyama K; Saiki S; Takahashi T; Matsuoka J; Hattori N
    J Int Med Res; 2012; 40(4):1483-91. PubMed ID: 22971500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
    Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
    Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
    Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
    J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis.
    Wang L; Hu W; Wang J; Qian W; Xiao H
    Mult Scler Relat Disord; 2016 Sep; 9():17-22. PubMed ID: 27645338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
    Quan C; Yu H; Qiao J; Xiao B; Zhao G; Wu Z; Li Z; Lu C
    Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated soluble syndecan-1 levels in neuromyelitis optica are associated with disease severity.
    Pei S; Zheng D; Wang Z; Hu X; Pan S; Wang H
    Cytokine; 2018 Nov; 111():140-145. PubMed ID: 30142535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
    Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
    Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
    Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
    Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CSF Levels of Neutrophil-Related Chemokines in Patients with Neuromyelitis Optica.
    Liu Z; Chen J; Wang Z; Wang Y; Zheng D; Wang H; Peng Y
    Ann Clin Transl Neurol; 2020 Jul; 7(7):1245-1251. PubMed ID: 32515897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
    Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
    J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis.
    Warabi Y; Yagi K; Hayashi H; Matsumoto Y
    J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
    Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
    Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential patterns of spinal cord and brain atrophy in NMO and MS.
    Liu Y; Wang J; Daams M; Weiler F; Hahn HK; Duan Y; Huang J; Ren Z; Ye J; Dong H; Vrenken H; Wattjes MP; Shi FD; Li K; Barkhof F
    Neurology; 2015 Apr; 84(14):1465-72. PubMed ID: 25762714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN).
    Chen X; Zeng C; Luo T; Ouyang Y; Lv F; Rumzan R; Wang Z; Li Q; Wang J; Hou H; Huang F; Li Y
    Eur J Radiol; 2012 Apr; 81(4):e633-9. PubMed ID: 22280874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.